PharmaVoice 100: Page 4

  • A portrait of Dr. Helen Thackray framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Helen Thackray
    Image attribution tooltip
    Profile // PharmaVoice 100

    Legacy Leaders: Dr. Helen Thackray

    The chief research and development officer at BioCryst Pharmaceuticals is leaning into decades of experience to advance a promising pipeline of rare disease products.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Henrietta Ukwu framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Henrietta Ukwu
    Image attribution tooltip
    Profile // PharmaVoice 100

    Legacy Leaders: Dr. Henrietta Ukwu

    Novavax’s regulatory head helped the company pull off its first approvals with the FDA and the EMA — but her accomplishments in pharma run deep.

    By • Sept. 6, 2022
  • A portrait of Houda Hachad framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Houda Hachad
    Image attribution tooltip
    Profile // PharmaVoice 100

    Tech Wizards: Houda Hachad

    This inventor and 'entrepreneurial scientist' is developing new technologies to manage data and use insights from genomic testing at AccessDx Laboratory.

    By Alexandra Pecci • Sept. 6, 2022
  • A portrait of Dr. Ian Walters framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Ian Walters
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Dr. Ian Walters

    How the CEO of Portage Biotech is steering cancer R&D in a new direction by advancing diverse drug platforms.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Jane Barlow framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Jane Barlow
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Dr. Jane Barlow

    The executive vice president and chief clinical officer of Real Endpoints is boosting patient access to innovative therapies through value-based payer agreements.

    By • Sept. 6, 2022
  • A portrait of Jeanne Magram framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jeanne Magram
    Image attribution tooltip
    Profile // PharmaVoice 100

    Innovators: Jeanne Magram

    Celsius Therapeutics’ CSO is turning ideas into approved medicines for patients with cancer and autoimmune diseases.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Jeff Fischer framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jeff Fischer
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Jeff Fischer

    The co-founder and president led Longhorn Vaccines and Diagnostics to an unprecedented surge in production of its testing tech at the height of COVID-19 and is now pursuing a universal flu vaccine.

    By Karissa Waddick • Sept. 6, 2022
  • A portrait of Jennifer Gottlieb framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jennifer Gottlieb
    Image attribution tooltip
    Profile // PharmaVoice 100

    DE&I Champions: Jennifer Gottlieb

    The global president and chief client officer of Real Chemistry is dedicated to ensuring all voices at the agency are heard and everyone has a seat at the table.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Jennifer Gould framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jennifer Gould
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Jennifer Gould

    How the director of marketing excellence at GSK is helping usher in a new era of pharma marketing and patient personalization with a collaborative cross-industry approach.

    By Karissa Waddick • Sept. 6, 2022
  • A portrait of Jennifer Kelly framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jennifer Kelly
    Image attribution tooltip
    Profile // PharmaVoice 100

    Tech Wizards: Jennifer Kelly

    The president of patient experience is helping transform clinical trials with an innovative platform.

    By • Sept. 6, 2022
  • A portrait of Dr. Jeremy Levin framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Jeremy Levin
    Image attribution tooltip
    Profile // PharmaVoice 100

    Legacy Leaders: Dr. Jeremy Levin

    Over his 30-year career, the founder, chairman and CEO of Ovid Therapeutics has demonstrated that he is a patient advocate, scientist, clinician and innovator at heart.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Jim Anthony framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jim Anthony
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Jim Anthony

    With a ready-for-anything attitude and a knack for relationship-building, the executive vice president and global head of Parexel Biotech is growing the CRO with a patient-first approach.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Jim Doherty framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jim Doherty
    Image attribution tooltip
    Profile // PharmaVoice 100

    Innovators: Jim Doherty

    Sage Therapeutics’ chief development officer is leveraging innovative development strategies to create success against hard-to-treat brain disorders.

    By • Sept. 6, 2022
  • A portrait of John Oyler framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by John Oyler
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: John Oyler

    The CEO of BeiGene is using innovative business strategies to help the oncology biotech quickly hit new heights.

    By • Sept. 6, 2022
  • A portrait of John Tsai framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by John Tsai
    Image attribution tooltip
    Profile // PharmaVoice 100

    Innovators: Dr. John Tsai

    How the former president of global drug development and chief medical officer at Novartis funneled his curiosity for engineering into a bold new approach to drug development.

    By • Sept. 6, 2022
  • A portrait of Johnna Wesley framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Johnna Wesley
    Image attribution tooltip
    Profile // PharmaVoice 100

    Innovators: Johnna Wesley

    The vice president of Type 1 diabetes and kidney disease research at Novo Nordisk is leading the charge to deliver paradigm-changing breakthroughs in the space.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Jonathan Ng framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Jonathan Ng
    Image attribution tooltip
    Profile // PharmaVoice 100

    Tech Wizards: Dr. Jonathan Ng

    As CEO of Iterative Scopes, Dr. Jonathan Ng is relentlessly committed to health equity while leveraging AI to establish new standards of care for detection and treatment of GI diseases.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Jonathan Steckbeck framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jonathan Steckbeck
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Jonathan Steckbeck

    The CEO, founder and president of Peptilogics is changing the game for the peptide medicine space with a promising pipeline and a disruptive discovery platform.

    By • Sept. 6, 2022
  • A portrait of Dr. Jordan Schecter framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Jordan Schecter
    Image attribution tooltip
    Profile // PharmaVoice 100

    Innovators: Dr. Jordan Schecter

    The VP of cellular therapy at Janssen has used collaboration, creative thinking and pragmatism to create a CAR-T multiple myeloma breakthrough.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Julie Kim framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Julie Kim
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Julie Kim

    The president of Takeda’s U.S. business unit and U.S. country head has steered through the pandemic, turning her aptitude for bringing people together into a master class in perseverance.

    By • Sept. 6, 2022
  • A portrait of Karin Jooss framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Karin Jooss
    Image attribution tooltip
    Profile // PharmaVoice 100

    Innovators: Karin Jooss

    The EVP and head of R&D at Gritstone bio is using her decades as a visionary drug developer to help the company advance vaccines for cancer.

    By • Sept. 6, 2022
  • A portrait of Kathy Lee-Sepsick framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Kathy Lee-Sepsick
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Kathy Lee-Sepsick

    Kathy Lee-Sepsick, the founder of Femasys, is determined to change the game in long-neglected areas of women’s healthcare, some of which haven’t had much innovation in more than a century.

    By Alexandra Pecci • Sept. 6, 2022
  • A portrait of Dr. Kerry Blanchard framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Everest Medicines
    Image attribution tooltip
    Profile // PharmaVoice 100

    Legacy Leaders: Dr. Kerry Blanchard

    The former CEO of Everest Medicines has focused on breaking new ground for China-based innovation.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Kim Johnson framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Kim Johnson
    Image attribution tooltip
    Profile // PharmaVoice 100

    Legacy Leaders: Kim Johnson

    The Global CEO is breathing fresh air into Ogilvy Health as she blazes a new trail at the storied agency.

    By Alexandra Pecci • Sept. 6, 2022
  • A portrait of Kuldeep Singh Rajput framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Kuldeep Singh Rajput
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Kuldeep Singh Rajput

    Bringing digital solutions to Big Pharmas adapting to a more patient-centric age, the CEO and founder of Biofourmis has instituted a flexible approach that keeps its tech on the leading edge.

    By • Sept. 6, 2022